Patient group	Treatments
* Note: This treatment option is under clinical evaluation.
Premenopausal, ER-positive or PR-positive	Chemotherapy plus tamoxifen, chemotherapy plus ovarian ablation/GnRH analog, chemotherapy plus tamoxifen plus ovarian ablation/GnRH analog*, ovarian ablation alone or with tamoxifen or GnRH alone or with tamoxifen
Premenopausal, ER-negative or PR-negative	Chemotherapy
Postmenopausal, ER-positive or PR-positive	Tamoxifen plus chemotherapy, tamoxifen alone
Postmenopausal, ER-negative or PR-negative	Chemotherapy
Older than 70 years	Tamoxifen alone; consider chemotherapy if receptor-negative